McBee disposed of 197,000 shares at $89.73 per share on August 10, realized through a derivative exercise.
The transaction included shares held directly and shares held indirectly through a spouse, the Brannin J. McBee 2022 Irrevocable Trust, and the Canis Major 2024 Irrevocable Trust LLC.
The activity was executed under a Rule 10b5-1 trading plan established on March 5 to provide structured liquidity.
Brannin McBee, the chief development officer of the firm, reported a sale of 197,000 shares of CoreWeave, Inc. (NASDAQ:CRWV) on August 10 for approximately $17.7 million, according to an SEC Form 4 filing, marking one of two such filings that day.
| Metric | Value |
|---|---|
| Shares sold | ~197,000 |
| Shares sold (directly held) | 144,000 |
| Shares sold (indirectly held) | 53,000 |
| Transaction value | $17.7 million |
Transaction value based on SEC Form 4 weighted average sale price ($89.73); post-transaction value based on the August 10 market close ($88.19).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-11) | $90.32 |
| Market Capitalization | $50 billion |
| Revenue (TTM) | $6.2 billion |
| Net Income (TTM) | -$1.6 billion |
CoreWeave operates as a specialized infrastructure-as-a-service provider in the rapidly expanding generative AI compute market, with a TTM revenue base of $6.2 billion and a market capitalization of $50 billion. The company differentiates itself through purpose-built infrastructure optimized for AI workloads, offering enterprises an alternative to hyperscale cloud providers with dedicated GPU and compute resources. Despite current net losses reflecting significant investments in capacity expansion and market penetration, CoreWeave is positioned to capitalize on the structural growth in enterprise AI infrastructure demand.
Whether CoreWeave is worth buying comes down to a single question, and a co-founder cashing in options doesn't answer it. McBee exercised 197,000 options for about $17.7 million on August 10, resulting in one of two Form 4 filings that day, yet he still holds a significant number of options across direct and indirect accounts, so his stake in the outcome is essentially untouched.
The bull case for investors is clearly immense growth. Revenue jumped 112% last quarter to $2.6 billion, the contracted backlog runs past $100 billion, and CoreWeave finally posted operating profit ahead of expectations, proof that its spending produces returns at scale. However, the bear case is also important. The company lost $626 million in the same quarter, and it carries roughly $35 billion in debt while leaning on a handful of huge customers to fill its backlog, so the economics remain a bit unproven even as the demand for now does not.
Ultimately, CoreWeave is a bet on execution. If it converts its backlog into cash faster than its debt costs pile up, the growth justifies the price. If it stumbles on capacity or a big customer pulls back, the leverage cuts the other way.
Before you buy stock in CoreWeave, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CoreWeave wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $421,511!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,960!*
Now, it’s worth noting Stock Advisor’s total average return is 981% — a market-crushing outperformance compared to 216% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of August 16, 2026.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.